Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study
Abstract Background The use of recombinant human follicle-stimulating hormone (r-hFSH) in ovarian stimulation protocols for infertility treatment in assisted reproductive technology (ART) clinical practice is well established. More recent advancements include the availability of biosimilar r-hFSH pr...
Saved in:
Main Authors: | Peter Sydow (Author), Norbert Gmeinwieser (Author), Katrin Pribbernow (Author), Christoph Keck (Author), Inka Wiegratz (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
by: Seyhan A, et al.
Published: (2011) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
by: Cota Ana Marcia M, et al.
Published: (2012) -
GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012) -
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
by: Raoul Orvieto
Published: (2023) -
Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
by: Hwu Yuh-Ming, et al.
Published: (2009)